$ 1.220 <%= Resources.Global.txtUp %>
Updated 23/05/2019
Change % 4.27% Stock price increasing
Change 0.05 Stock price increasing
Volume 421,746
High $ 1.230
Low $ 1.150
Open $ 1.150
ISIN
Prev close $ 1.170
# of shares 92.35M
Market cap 112.67M USD
Intraday

Market closed
Trevena Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1.22 -9.6% Stock price decreasing -17.0% Stock price decreasing -14.7% Stock price decreasing 90.6% Stock price increasing -29.9% Stock price decreasing
Powered by TradingView

News about Trevena Inc

  • English
  • Regulatory news

Company profile

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 May 2019 20:50:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190514.2 - EUROWEB7 - 2019-05-25 21:50:15 - 2019-05-25 20:50:15 - 1000 - Website: OKAY